TBPMF News and Press, Tetra Bio-Pharma Inc From 01/21/20

Tetra Bio-Pharma ( OTCQB:TBPMF ) inks an agreement with Echelon Wealth Partners for the purchase of ~18.9M units at C$0.53 per unit for a total of C$10M. More news on: Tetra Bio-Pharma Inc., Healthcare stocks news, Read more ...

Phoenix, Arizona--(Newsfile Corp. - January 21, 2020) - The Stock Day Podcast welcomed Tetra Bio-Pharma (TSXV: TBP) (OTCQB: TBPMF), a biopharmaceutical leader in cannabinoid- based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringin...

Tetra Bio-Pharma Announces $10.0 Million Bought Deal Offering Canada NewsWire OTTAWA, Jan. 21, 2020 /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES / OTTAWA , Jan. 21, 2020 /CNW/ - Tetra Bio-Pharma Inc. (TSXV:TBP) ("Tetra" or "T...

     Tetra to partner with a Contract Sales Organization (CSO) for both TERPACAN™ and AWAYE™                 Tetra expanding sales partnership agreements to the Middle East        O...

OTTAWA, Jan. 17, 2020 (GLOBE NEWSWIRE) -- Following its November 26 th , 2019 Press Release, Tetra Bio Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF) today announced that Health Canada has granted two Drug Identification Numbers (DIN) for the fi...

FDA Feedback continues to support the development of QIXLEEF for second- or third-line therapy for adult patients with uncontrolled pain FDA advice consistent with previous feedback paving the way for the marketing approval of QIXLEEF OTTAWA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Tetra...

Phoenix, Arizona--(Newsfile Corp. - December 19, 2019) - The Stock Day Podcast welcomed Tetra Bio-Pharma (OTC: TBPMF) ("the Company"), a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada authorized, and FDA reviewed, clinical program aimed at bri...

Submitted data to U.S. Food and Drug Administration for surrogate endpoint to be used for an Accelerated Approval                 Two OTC DIN applications pass Health Canada screening phase OTTAWA, Dec. 19, 2019 (GLOBE NEWSWIRE) ...

The prospect of cannabis investments took a hit in 2019, as the sector continues its evolution what are companies in the space looking forwards to in 2020? But now the market is entering a critical time in its maturation process, according to various players of the cannabis industry. Inves...

OTTAWA, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (“ Tetra ” or the “ Company ”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced the signing of a definitive agreement with Azevedos Ind...